Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer.
Exportin 1 抑制剂 Selinexor 联合多西他赛治疗既往接受过治疗的晚期 KRAS 突变型非小细胞肺癌的 I/II 期试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1722
von Itzstein Mitchell S, Burns Timothy F, Dowell Jonathan E, Horn Leora, Camidge D Ross, York Sally J, Eaton Keith D, Kyle Kelly, Fattah Farjana, Liu Jialiang, Mu-Mosley Hong, Gupta Arjun, Nadeem Urooba, Gao Ang, Zhang Song, Gerber David E